Breaking News Instant updates and real-time market news.

CDNA

CareDx

$39.54

0.945 (2.45%)

08:07
07/11/19
07/11
08:07
07/11/19
08:07

CareDx says it 'applauds' White House efforts to reform kidney health system

CareDx said it "applauds the White House and Department of Health and Human Services Secretary Alex Azar on their recent policy announcement aimed at improving the lives of the more than 726,000 Americans with end-stage renal disease and removing disincentives for transplantation...President Trump's executive order aims to reform the nation's organ transplant and kidney dialysis systems and includes proposals to improve the performance of organ procurement organizations, incentivize living kidney and liver donation, ensure patients with kidney disease receive the best dialysis care available at an affordable cost, and increase the number of available organs for transplantation." "At CareDx, we believe transplantation is better than dialysis because it promises better quality of life for kidney patients, provides better outcomes and is demonstrably more cost effective for the healthcare system overall," said CEO Peter Maag. "We are excited by the Administration's enthusiasm to support kidney health and promote the benefits of transplantation and look forward to working with the administration on these ambitious policy proposals moving forward."

CDNA CareDx
$39.54

0.945 (2.45%)

03/28/19
RAJA
03/28/19
NO CHANGE
RAJA
Strong Buy
CareDx lawsuit against Natera 'not unexpected,' says Raymond James
Raymond James analyst John Hsu notes that CareDx (CDNA) announced the filing of a patent infringement lawsuit against Natera (NTRA), which was "not unexpected." The analyst sees the lawsuit as consistent with management seeking to protect the company's intellectual property, and notes that the court process could take up to three years. While this lawsuit is a "logical course of action," Hsu believes CareDx remains focused on building its moat in kidney transplant, with sales force investments and a focus on integration with hospital electronic medical records. Overall, the analyst still views 2019's main focus on other activities to strengthen a "significant head start on the back of a best-in-class product launch in 2018." He reiterates a Strong Buy rating on CareDx shares.
05/09/19
PIPR
05/09/19
NO CHANGE
Target $50
PIPR
Overweight
CareDx price target raised to $50 from $42 at Piper Jaffray
Piper Jaffray analyst William Quirk raised his price target for CareDx to $50 from $42 following the company's better than expected Q1 results and increased outlook. CareDx has widened its "competitive moat" in transplant medicine with KidneyCare, Quirk tells investors in a research note. The stock remains his top small cap idea with an Overweight rating.
05/09/19
HCWC
05/09/19
UPGRADE
Target $43
HCWC
Buy
CareDx upgraded to Buy from Neutral at H.C. Wainwright
H.C. Wainwright analyst Raghuram Selvaraju upgraded CareDx to Buy from Neutral and raised his price target for the shares to $43 from $30. The company in Q1 posted positive EBITDA for the third consecutive quarter, Selvaraju tells investors in a research note. The analyst believes CareDx could achieve positive EBITDA sustainably going forward.
07/10/19
RAJA
07/10/19
NO CHANGE
Target $46
RAJA
Strong Buy
CareDx should get 'Trump Bump' from kidney care speech, says Raymond James
Noting that President Donald Trump is expected to discuss policies to increase the volume of organ transplants, including kidneys by 17,000 over time, in a speech scheduled for 11 am ET this morning, Raymond James analyst John Hsu said he anticipates a positive tailwind for organ transplants and a "Trump Bump" for CareDx. While Hsu said he thinks a target to nearly double the current kidney transplant rate is "undoubtedly an ambitious goal" and he sees a 13-15% increase in year one as more likely, he raised his revenue estimates for CareDx given an expected acceleration from the 5% typical increase in annual kidney transplants. He maintains a Strong Buy rating and $46 price target on CareDx shares.

TODAY'S FREE FLY STORIES

AMD

AMD

$33.59

-0.23 (-0.68%)

, INTC

Intel

$49.39

0.22 (0.45%)

04:59
07/18/19
07/18
04:59
07/18/19
04:59
Downgrade
AMD downgraded to Neutral from Buy at Mizuho »

Mizuho analyst Vijay…

AMD

AMD

$33.59

-0.23 (-0.68%)

INTC

Intel

$49.39

0.22 (0.45%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jul

  • 30

    Jul

04:55
07/18/19
07/18
04:55
07/18/19
04:55
General news
Jobless Claims to be reported at 08:30 »

Week of 7/13 Jobless…

04:55
07/18/19
07/18
04:55
07/18/19
04:55
General news
Breaking General news story  »

6-Month Bill Announcement…

GMRE

Global Medical REIT

$10.51

-0.15 (-1.41%)

04:55
07/18/19
07/18
04:55
07/18/19
04:55
Conference/Events
Global Medical REIT management to meet with Oppenheimer »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jul

  • 08

    Aug

TORC

ResTORbio

$10.42

0.19 (1.86%)

04:55
07/18/19
07/18
04:55
07/18/19
04:55
Conference/Events
ResTORbio management to meet with Wedbush »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jul

SUPV

Grupo Supervielle

$8.12

0.13 (1.63%)

04:55
07/18/19
07/18
04:55
07/18/19
04:55
Conference/Events
Grupo Supervielle management to meet with UBS »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jul

  • 19

    Jul

04:55
07/18/19
07/18
04:55
07/18/19
04:55
General news
Philadelphia Fed Business Outlook Survey General Conditions Index to be reported at 08:30 »

July Philadelphia Fed…

04:55
07/18/19
07/18
04:55
07/18/19
04:55
General news
Leading Indicators to be reported at 10:00 »

June Leading Indicators…

CAMP

CalAmp

$10.82

-0.46 (-4.08%)

04:55
07/18/19
07/18
04:55
07/18/19
04:55
Conference/Events
CalAmp participates in a conference call with Northland »

Conference call with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jul

  • 24

    Jul

  • 06

    Aug

04:55
07/18/19
07/18
04:55
07/18/19
04:55
General news
Breaking General news story  »

Week of 7/12 EIA Natural…

04:55
07/18/19
07/18
04:55
07/18/19
04:55
General news
Breaking General news story  »

4-Week Bill Auction to be…

CASY

Casey's General Stores

$160.43

0.08 (0.05%)

04:55
07/18/19
07/18
04:55
07/18/19
04:55
Conference/Events
Casey's General Stores management to meet with Northcoast »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jul

  • 13

    Nov

OPNT

Opiant Pharmaceuticals

$13.24

-0.25 (-1.85%)

04:55
07/18/19
07/18
04:55
07/18/19
04:55
Conference/Events
Opiant Pharmaceuticals management to meet with Northland »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jul

  • 19

    Jul

ACAD

Acadia

$25.56

-0.72 (-2.74%)

, BIIB

Biogen

$229.39

-2.17 (-0.94%)

04:55
07/18/19
07/18
04:55
07/18/19
04:55
Conference/Events
Alzheimer's Association to hold a conference »

Alzheimer's…

ACAD

Acadia

$25.56

-0.72 (-2.74%)

BIIB

Biogen

$229.39

-2.17 (-0.94%)

CRL

Charles River

$135.30

0.08 (0.06%)

DGX

Quest Diagnostics

$100.18

-1.28 (-1.26%)

ESALY

Eisai

$0.00

(0.00%)

PKI

PerkinElmer

$95.10

-0.24 (-0.25%)

RHHBY

Roche

$0.00

(0.00%)

MRK

Merck

$81.93

0.36 (0.44%)

NSTG

NanoString

$30.44

-0.06 (-0.20%)

PRAH

PRA Health

$98.05

-0.43 (-0.44%)

QTRX

Quanterix

$31.45

0.37 (1.19%)

SYNH

Syneos Health

$47.64

-1.07 (-2.20%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jul

  • 23

    Jul

  • 25

    Jul

  • 25

    Jul

  • 29

    Jul

  • 30

    Jul

  • 31

    Jul

  • 31

    Jul

  • 31

    Jul

  • 01

    Aug

  • 06

    Aug

  • 06

    Aug

  • 08

    Aug

  • 18

    Aug

  • 19

    Aug

  • 26

    Aug

  • 02

    Sep

  • 09

    Sep

  • 13

    Sep

  • 16

    Sep

  • 20

    Sep

  • 02

    Oct

  • 04

    Nov

CGC

Canopy Growth

$36.57

1.015 (2.85%)

04:55
07/18/19
07/18
04:55
07/18/19
04:55
Conference/Events
Canopy Growth management to meet with Seaport Global »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jul

04:55
07/18/19
07/18
04:55
07/18/19
04:55
Conference/Events
The Brookings Institution to hold a conference on the US-China Trade War »

The Global Economy &…

04:55
07/18/19
07/18
04:55
07/18/19
04:55
Conference/Events
House Judiciary Committee to hold a hearing »

The Subcommittee on…

04:55
07/18/19
07/18
04:55
07/18/19
04:55
General news
Breaking General news story  »

8-Week Bill Auction to be…

04:55
07/18/19
07/18
04:55
07/18/19
04:55
General news
Breaking General news story  »

Week of 7/17 Fed Balance…

04:55
07/18/19
07/18
04:55
07/18/19
04:55
General news
Breaking General news story  »

New York Federal Reserve…

UBSFY

Ubisoft

$0.00

(0.00%)

, TTWO

Take-Two

$117.64

0.15 (0.13%)

04:55
07/18/19
07/18
04:55
07/18/19
04:55
Conference/Events
Wedbush digital media analyst to hold an analyst/industry conference call »

Digital Media Analyst…

UBSFY

Ubisoft

$0.00

(0.00%)

TTWO

Take-Two

$117.64

0.15 (0.13%)

NTDOY

Nintendo

$0.00

(0.00%)

GME

GameStop

$4.39

-0.245 (-5.29%)

EA

Electronic Arts

$89.72

0.15 (0.17%)

ATVI

Activision Blizzard

$46.69

-0.29 (-0.62%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jul

  • 30

    Jul

  • 05

    Aug

  • 08

    Aug

  • 08

    Aug

  • 05

    Sep

  • 13

    Nov

GLMD

Galmed

$6.30

-0.2 (-3.08%)

, CBAY

CymaBay

$6.39

-0.15 (-2.29%)

04:55
07/18/19
07/18
04:55
07/18/19
04:55
Conference/Events
Cantor Fitzgerald biotech analysts to hold a KOL luncheon meeting »

Biotech Analysts Young…

GLMD

Galmed

$6.30

-0.2 (-3.08%)

CBAY

CymaBay

$6.39

-0.15 (-2.29%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jul

04:55
07/18/19
07/18
04:55
07/18/19
04:55
Conference/Events
William Blair enterprise & cloud infrastructure analyst to hold a group luncheon »

Enterprise & Cloud…

DOVA

Dova Pharmaceuticals

$16.01

-0.06 (-0.37%)

04:55
07/18/19
07/18
04:55
07/18/19
04:55
Conference/Events
Dova Pharmaceuticals management to meet with Jefferies »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jul

04:55
07/18/19
07/18
04:55
07/18/19
04:55
Conference/Events
Piper Jaffray to hold a conference »

BioInsights KOL Series…

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.